Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      ED arrests former Andhra Bank director in Sterling Biotech loan fraud case

      ED arrests former Andhra Bank director in Sterling Biotech loan fraud case

      Ruby Khatun Khatun15 Jan 2018 10:30 AM IST
      New Delhi: A former Director of Andhra Bank has been arrested by the Enforcement Directorate (ED) in connection with its money laundering probe in the...
      Fortis, RHT Health extend discussion time by 30 days

      Fortis, RHT Health extend discussion time by 30 days

      Ruby Khatun Khatun15 Jan 2018 10:00 AM IST
      New Delhi: Fortis Health Management and Singapore-listed RHT Health Trust have extended exclusivity period to finalize the proposed acquisition by 30...
      State, Johnson and Johnson partner for rural health training

      State, Johnson and Johnson partner for rural health training

      Ruby Khatun Khatun15 Jan 2018 10:00 AM IST
      Mumbai: The Maharashtra Health department and private firm Johnson and Johnson entered into an agreement to train rural midwives and accredited social...
      Sparks price for Luxturna blindness gene therapy too high: ICER

      Spark's price for Luxturna blindness gene therapy too high: ICER

      Ruby Khatun Khatun15 Jan 2018 9:45 AM IST
      The proposed price for Spark Therapeutics Inc’s groundbreaking one-time gene therapy for a rare form of blindness is far too high, an independent U.S....
      Google venture arm backs UK universal flu vaccine company

      Google venture arm backs UK universal flu vaccine company

      Ruby Khatun Khatun15 Jan 2018 9:30 AM IST
      LONDON: A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised 20 million pounds...
      Aurobindo, Zydus Cadila, Torrent Pharma show interest to buy Sanofi 2 billion dollar European generics business

      Aurobindo, Zydus Cadila, Torrent Pharma show interest to buy Sanofi 2 billion dollar European generics business

      Ruby Khatun Khatun14 Jan 2018 11:51 AM IST
      MUMBAI: Aurobindo, Zydus Cadila, Torrent Pharma and Intas have shown their interest to buy the European generics business of pharma giant...
      HC refrains from staying Patanjalis toilet cleaner ad

      HC refrains from staying Patanjali's toilet cleaner ad

      Ruby Khatun Khatun14 Jan 2018 10:45 AM IST
      New Delhi: The Delhi High Court declined UK-based Reckitt Benckiser's plea to pass an interim order restraining Baba Ramdev's Patanjali Ayurved Ltd...
      Haryana govt mulling insurance scheme in health sector: CM

      Haryana govt mulling insurance scheme in health sector: CM

      Ruby Khatun Khatun14 Jan 2018 10:30 AM IST
      Panchkula: Haryana Chief Minister Manohar Lal Khattar said his government is contemplating implementation of an insurance scheme in the health sector...
      USFDA approves expanded use of AstraZeneca cancer drug

      USFDA approves expanded use of AstraZeneca cancer drug

      Ruby Khatun Khatun14 Jan 2018 10:15 AM IST
      The U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc’s cancer drug Lynparza to include patients with...
      Plan to reduce medicine prices faces industry pushback: Report

      Plan to reduce medicine prices faces industry pushback: Report

      Ruby Khatun Khatun14 Jan 2018 10:08 AM IST
      India’s proposal to curb drug prices by stripping generic medicines of their brand names has stalled after the plan faced pushback from the country’s...
      Roches star MS medicine Ocrevus wins EU approval

      Roche's star MS medicine Ocrevus wins EU approval

      Ruby Khatun Khatun14 Jan 2018 9:45 AM IST
      ZURICH: The European Union approved Roche’s multiple sclerosis medicine Ocrevus, one the Swiss company’s key new drugs that likely neared $1 billion...
      Merck Foundation partners with Malaysia and India to build healthcare capacity in Africa

      Merck Foundation partners with Malaysia and India to build healthcare capacity in Africa

      Ruby Khatun Khatun14 Jan 2018 9:30 AM IST
      New Delhi: Merck Foundation (MF), a non-profit company and subsidiary of Merck KGaA Germany, and the University of Malaya (UM), Malaysia's oldest and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok